| Issue Date | Title | Involved Person(s) |
| Feb-2024 | The WHO Mental Health Gap Action Programme for mental, neurological, and substance use conditions : the new and updated guideline recommendations | Brohan, Elaine; Chowdhary, Neerja; Dua, Tarun; Barbui, Corrado; Thornicroft, Graham; Kestel, Dévora; Ali, Amza; Assanangkornchai, Sawitri; Brodaty, Henry; Carli, Vladimir; El Chammay, Rabih; Chang, Odille; Collins, Pamela Y.; Cuijpers, Pim; Dowrick, Christopher; Eaton, Julian; Ferri, Cleusa P.; Fortes, Sandra; Hengartner, Michael P.; Humayun, Asma; Jette, Nathalie; de Vries, Petrus J.; Medina-Mora, Maria Elena; Murthy, Pratima; Nadera, Dinah; Newton, Charles; Njenga, Michael; Omigbodun, Olayinka; Rahimi-Movaghar, Afarin; Rahman, Atif; Fortunato dos Santos, Palmira; Saxena, Shekhar; Vijayakumar, Lakshmi; Wang, Huali; Wattanavitukul, Pichayanan; Yewnetu, Enat; Carswell, Ken; Chatterjee, Sudipto; Fatima, Batool; Fleischmann, Alexandra; Gray, Brandon; Hanlon, Charlotte; Hanna, Fahmy; Krupchanka, Dzmitry; Malik, Aiysha; van Ommeren, Mark; Poznyak, Vladimir; Seeher, Katrin; Servili, Chiara; Weissbecker, Inka; Baingana, Florence; Alfonzo Bello, Luis; Bruni, Andrea; Jorge Dos Santos Ferreira Borges Bigot, Ana Carina; Dorji, Chencho; Vandendyck, Martin; Lazeri, Ledia; Monteiro, Maristela Goldnadel; Rani, Manju; Saeed, Khalid; e Souza, Renato Oliveira; Ameyan, Wole; Baltag, Valentina; Branca, Francesco; Cappello, Bernadette; Cometto, Giorgio; Dalil, Suraya; Gabrielli, Albis; Huttner, Benedikt; Jaramillo, Ernesto; Khan, Taskeen; King, Jonathan; Krech, Ruediger; Roebbel, Nathalie; Tran, Nhan; Sumi, Yuka; Syed, Shams |
| 2024 | Suicidality emerging from rapid Venlafaxine discontinuation | Kostic, Milutin; Plöderl, Martin; Hengartner, Michael; Buzejic, Jelena |
| 2-Dec-2023 | Wirksamkeitsforschung heute : das Beispiel Depressionsbehandlungen | Hengartner, Michael Pascal |
| 28-Oct-2023 | Computerspielsucht und Depressivität | Hengartner, Michael Pascal |
| Sep-2023 | Re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder" by Strawn et al. : concerning harm-benefit ratio in a recent trial about Escitalopram for generalized anxiety disorder | Plöderl, Martin; Horowitz, Mark A.; Hengartner, Michael P. |
| 16-Jun-2023 | The serotonin hypothesis of depression : both long discarded and still supported? | Moncrieff, Joanna; Cooper, Ruth E.; Stockmann, Tom; Amendola, Simone; Hengartner, Michael P.; Plöderl, Martin; Horowitz, Mark A. |
| 23-Mar-2023 | Modelle, Diagnostik und Behandlung der Depression in der Hausarztmedizin | Hengartner, Michael P. |
| 9-Feb-2023 | No clear evidence of reduced brain serotonin release capacity in patients with depression | Hengartner, Michael P.; Plöderl, Martin |
| Jan-2023 | Wichtig, dass Pflegefachpersonen wissenschaftliche Evidenz kennen | Hengartner, Michael P. |
| 2023 | Publication and citation biases in observational studies about antidepressants and suicides | Plöderl, Martin; Hengartner, Michael P. |
| 14-Feb-2022 | Opinion: Regulators are approving drugs without clear evidence that they work | Hengartner, Michael Pascal |
| 2022 | Suizidpräventive Effekte von Ketamin und Esketamin | Plöderl, Martin; Hengartner, Michael P.; Volkmann, Constantin |
| Dec-2021 | Evidence-biased antidepressant prescription : overmedicalisation, flawed research, and conflicts of interest | Hengartner, Michael P. |
| 8-Nov-2021 | Learning about the course of suicidal behavior but not about the effects of SSRIs | Plöderl, Martin; Hengartner, Michael Pascal |
| Mar-2021 | Antidepressiva – eine kritische Analyse der Verschreibungspraxis und Wirksamkeit | Hengartner, Michael Pascal |
